Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» testosterone
testosterone
Lipocine testosterone therapy meets late-stage study goals
Yahoo/Reuters
Wed, 09/24/14 - 09:37 am
Lipocine
testosterone
LPCN 1021
FDA advisers shoot down Clarus' pitch for a new low-T drug
Fierce Biotech
Fri, 09/19/14 - 08:58 am
FDA
Clarus Therapeutics
advisory panels
Rextoro
testosterone
FDA panel recommends scaling back testosterone use in men, citing little evidence of benefit
Yahoo/AP
Thu, 09/18/14 - 08:59 am
FDA
advisory panels
testosterone
AbbVie
Eli Lilly
Possible Heart Risk With Testosterone Spurs Debate on Use
Bloomberg
Tue, 09/16/14 - 09:24 am
testosterone
Eli Lilly
Auxilium
Rextoro
Clarus Therapeutics
FDA: Little evidence to support testosterone drugs
Yahoo/AP
Wed, 09/3/14 - 10:18 pm
FDA
testosterone
Androgel
Fortesta
Eli Lilly
AbbVie
Endo Health Solutions
Upsher-Smith
Repros says its testosterone drug found superior in study
Yahoo/Reuters
Thu, 08/28/14 - 08:52 am
testosterone
Repros Therapeutics
Androxal
Heart Warnings for Low T Drugs? Health Canada Says ‘Yes,’ but FDA Isn’t Sure
WSJ Online
Thu, 07/17/14 - 10:04 am
testosterone
warnings
Canada
FDA
Testosterone elevating drugs free of heart attack risk, study says
Fierce Pharma
Mon, 07/7/14 - 07:31 pm
testosterone
AbbVie
Androgel
heart attacks
Eli Lilly
Pfizer
FDA asks for wider warning on testosterone products
Yahoo/Reuters
Fri, 06/20/14 - 09:41 am
FDA
testosterone
AbbVie
Endo Health Solutions
Abbott, AbbVie get to defend testosterone lawsuits on their own turf
Fierce Pharma
Mon, 06/9/14 - 11:28 am
Abbott
AbbVie
testosterone
Androgel
Biotech Auxilium Boosts Position In Men's Health Care
Investors.com
Wed, 04/2/14 - 07:25 am
Auxilium
erectile dysfunction
testosterone
Endo Health's Aveed testosterone injection approved by FDA
Yahoo/Fly on the Wall
Thu, 03/6/14 - 09:58 am
Aveed
Endo Health Solutions
FDA
testosterone
Public Citizen says FDA should add heart warning to popular testosterone drugs for men
Yahoo/AP
Tue, 02/25/14 - 07:27 am
FDA
testosterone
Public Citizen
Androgel
Androderm
Fortesta
Axiron
Watson Pharmaceuticals
AbbVie
Eli Lilly
Endo Health Solutions
Pharma's Reputation Flagging Due To Low Testosterone
Forbes
Wed, 02/5/14 - 03:15 pm
testosterone
Heart Attack Risk of Testosterone Drugs Under U.S. Review
Bloomberg
Sat, 02/1/14 - 10:54 am
testosterone
FDA Schedules Face to Face Meeting With Repros to Discuss Androxal(R) Efficacy
Yahoo
Mon, 11/25/13 - 10:31 am
Androxal
FDA
Repros
testosterone
Testosterone Drugs Raise Heart Risk in $1 Billion Market
Bloomberg
Wed, 11/6/13 - 08:34 am
testosterone
Eli Lilly
Actavis
Androgel
Axiron
AbbVie
Androderm
Repros plummets as FDA questions testosterone drug data
Fierce Biotech
Thu, 10/24/13 - 10:26 am
FDA
Repros Therapeutics
testosterone
Androxal
Repros reported additional topline results from study for Androxal
Yahoo/Fly on the Wall
Wed, 09/18/13 - 10:37 am
Androxal
Repros Therapeutics
testosterone
Repros Therapeutics: Winning The Battle But Losing The War?
Seeking Alpha
Tue, 09/17/13 - 09:34 am
Repros Therapeutics
AstraZeneca
Sanofi
Androxal
testosterone
Pages
« first
‹ previous
1
2
3
4
next ›
last »